03:37 AM EST, 02/27/2025 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) reported Q4 earnings late Wednesday of $0.01 per diluted share, swinging from a loss of $0.46 a year earlier.

Analysts polled by FactSet expected a loss of $0.22.

Revenue for the quarter ended Dec. 31 was $282.6 million, compared with $196.8 million a year earlier.

For Q1, the company expects sales to be about $219 million to $224 million. Analysts polled by FactSet expect $220.8 million.

The company said it expects 2025 revenue of $997 million to $1.01 billion. Analysts polled by FactSet expect $1.01 billion.

The company's shares fell more than 18% in after-hours activity Wednesday.